Variant report
Variant | nsv963983 |
---|---|
Chromosome Location | chr4:93745359-93755269 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:16)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:16 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr4:93753510-93753717 | H1-hESC | embryonic stem cell: | n/a | n/a |
2 | CTCF | chr4:93746868-93746973 | GM20000 | blood: | n/a | n/a |
3 | FOS | chr4:93746504-93746794 | MCF10A-Er-Src | breast: | n/a | n/a |
4 | FOS | chr4:93746524-93746674 | MCF10A-Er-Src | breast: | n/a | n/a |
5 | FOS | chr4:93746503-93746754 | MCF10A-Er-Src | breast: | n/a | n/a |
6 | POLR2A | chr4:93752794-93753008 | H1-hESC | embryonic stem cell: | n/a | n/a |
7 | POLR2A | chr4:93750925-93751181 | H1-hESC | embryonic stem cell: | n/a | n/a |
8 | POLR2A | chr4:93746413-93746516 | H1-hESC | embryonic stem cell: | n/a | n/a |
9 | POLR2A | chr4:93751416-93751570 | MCF10A-Er-Src | breast: | n/a | n/a |
10 | POLR2A | chr4:93746104-93746288 | MCF10A-Er-Src | breast: | n/a | n/a |
11 | POLR2A | chr4:93754299-93754311 | H1-hESC | embryonic stem cell: | n/a | n/a |
12 | POLR2A | chr4:93746452-93746706 | H1-hESC | embryonic stem cell: | n/a | n/a |
13 | POLR2A | chr4:93752890-93752965 | H1-hESC | embryonic stem cell: | n/a | n/a |
14 | POLR2A | chr4:93751883-93752346 | H1-neurons | neurons: | n/a | n/a |
15 | POLR2A | chr4:93751919-93752304 | H1-neurons | neurons: | n/a | n/a |
16 | STAT3 | chr4:93754283-93754307 | MCF10A-Er-Src | breast: | n/a | n/a |
No data |
No data |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-RP11-9B6.1.1-2 | chr4:93754836-93755124 | ENSG00000248627.1 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000249239 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs115204679 | chr4:93745361-93745362 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs540772650 | chr4:93745376-93745377 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs560796621 | chr4:93745385-93745386 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs542688902 | chr4:93745452-93745453 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs529725448 | chr4:93745455-93745456 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs144956391 | chr4:93745498-93745499 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs564030557 | chr4:93745502-93745503 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs77071807 | chr4:93745508-93745509 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs552811736 | chr4:93745517-93745518 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs566325756 | chr4:93745546-93745547 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs528675636 | chr4:93745567-93745568 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs538255416 | chr4:93745622-93745623 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs528082173 | chr4:93745706-93745707 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs553615618 | chr4:93745736-93745737 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs543663080 | chr4:93745737-93745738 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs548696661 | chr4:93745912-93745913 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs185497611 | chr4:93745927-93745928 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs148549586 | chr4:93745932-93745933 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs557029181 | chr4:93745968-93745969 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs113804403 | chr4:93746036-93746037 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs530721612 | chr4:93746050-93746051 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs35937917 | chr4:93746137-93746138 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs558958689 | chr4:93746138-93746139 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs70942932 | chr4:93746145-93746146 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs142924955 | chr4:93746161-93746162 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs558423390 | chr4:93746169-93746170 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs192810581 | chr4:93746195-93746196 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs550323590 | chr4:93746196-93746197 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs567143227 | chr4:93746218-93746219 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs373870977 | chr4:93746260-93746261 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs184369208 | chr4:93746274-93746275 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs151102218 | chr4:93746349-93746350 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs377133487 | chr4:93746366-93746367 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs563096255 | chr4:93746371-93746372 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs576472783 | chr4:93746372-93746373 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs532143203 | chr4:93746399-93746400 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs188408094 | chr4:93746403-93746404 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs141092760 | chr4:93746438-93746439 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs146913357 | chr4:93746479-93746480 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs181263814 | chr4:93746511-93746512 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs568545899 | chr4:93746520-93746521 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs386677307 | chr4:93746537-93746538 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs184087422 | chr4:93746544-93746545 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs77736427 | chr4:93746554-93746555 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs189102699 | chr4:93746560-93746561 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs375705380 | chr4:93746658-93746659 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs370268302 | chr4:93746668-93746669 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs181042308 | chr4:93746670-93746671 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs187163487 | chr4:93746675-93746676 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs565600972 | chr4:93746682-93746683 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Parkinson disease | 18923514 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 18414403 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Mental retardation | 20522426 | CNVD |
delayed speech | 20522426 | CNVD |
growth disorder | 20522426 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Colorectal cancer | 20459617 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Parkinson disease | 20877625 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Cancer | 19907438 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Breast cancer | 22522925 | CNVD |
Autism | 20841430 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Cancer | 20164919 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:93709200-93752000 | Weak transcription | H1 Cell Line | embryonic stem cell |
2 | chr4:93738600-93753600 | Weak transcription | H9 Cell Line | embryonic stem cell |
3 | chr4:93745200-93746200 | Weak transcription | Fetal Intestine Large | intestine |
4 | chr4:93745200-93746200 | Weak transcription | Fetal Intestine Small | intestine |
5 | chr4:93745400-93758200 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
6 | chr4:93746200-93747200 | Enhancers | Fetal Heart | heart |
7 | chr4:93746200-93747200 | Enhancers | Fetal Intestine Large | intestine |
8 | chr4:93746200-93747200 | Enhancers | Fetal Intestine Small | intestine |
9 | chr4:93746400-93747000 | Enhancers | Fetal Lung | lung |
10 | chr4:93746600-93746800 | Enhancers | Fetal Brain Male | brain |
11 | chr4:93746800-93747200 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
12 | chr4:93747200-93747400 | Flanking Active TSS | Fetal Heart | heart |
13 | chr4:93747400-93747600 | Enhancers | Fetal Brain Male | brain |
14 | chr4:93752000-93752400 | Strong transcription | H1 Cell Line | embryonic stem cell |
15 | chr4:93752400-93757800 | Weak transcription | H1 Cell Line | embryonic stem cell |